Tricuspid valve disease and cardiac implantable electronic devices - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Heart Journal Année : 2023

Tricuspid valve disease and cardiac implantable electronic devices

Fabien Praz
Osama Soliman
Manuel Barreiro-de Acosta
Joao L. Cavalcante
Tom de Potter
Torsten Doenst
Kai Friedrichs
Nicole Karam
Eloi Marijon
Suneet Mittal
Aldo Rinaldi
Piotr Rudzinski
M Russo
Nina Wunderlich
  • Fonction : Auteur

Résumé

The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.
Fichier non déposé

Dates et versions

hal-04350595 , version 1 (18-12-2023)

Identifiants

Citer

Martin Andreas Volkl, Haran Burri, Fabien Praz, Osama Soliman, Luigi Badano, et al.. Tricuspid valve disease and cardiac implantable electronic devices. European Heart Journal, 2023, European Heart Journal, ⟨10.1093/eurheartj/ehad783⟩. ⟨hal-04350595⟩
16 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More